A Case of Chronic Mveloaenous Leukemia That Developed Fibrous Pericarditis Owing to Nilotinib Use

MIURA SHOGO; MURASE KAZUYUKI; SAKURADA AKIRA; TAKADA KOICHI; IYAMA SATOSHI; SATO TSUTOMU; SATO YASUSHI; MIYANISHI KOJI; KOBUNE MASAYOSHI; MURANAKA ATSUKO; TACHIBANA KAZUTOSHI; KATO JUNJI

Art

J-GLOBAL ID：201702264970271269 Reference number：17A0706974

A Case of Chronic Mveloaenous Leukemia That Developed Fibrous Pericarditis Owing to Nilotinib Use

ニロチニブにより線維性心膜炎を発症した慢性骨髄性白血病の1例

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=17A0706974&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0706974&from=J-GLOBAL&jstjournalNo=Z0938A") }}

Author (12)： , , , , , , , , , , ,
Material：
Volume： 44 Issue： 6 Page： 529-531 Publication year： Jun. 15, 2017
JST Material Number： Z0938A ISSN： 0385-0684 Document type： Article
Article type：原著論文 Country of issue： Japan (JPN) Language： JAPANESE (JA)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0706974&from=J-GLOBAL&jstjournalNo=Z0938A") }}

Blood cell tumors(=neoplasms) , Drug therapy(=pharmacotherapy)for tumors , Poisoning in general

Reference (9)：

Hochhaus A, Saglio G, Hughes TP, et al: Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial. Leukemia 30 (5) : 1044- 1054, 2016.
Hurrell DG, Nishimura RA, Higano ST, et al: Value of dynamic respiratory changes in left and right ventricular pressures for the diagnosis of constrictive pericarditis. Circulation 93 (11): 2007-2013, 1996.
Cowan-Jacob SW, Guez V, Fendrich G, et al: Imatinib (STI571) resistance in chronic myelogenous leukemia: molecular basis of the underlying mechanisms and potential strategies for treatment. Mini Rev Med Chem 4 (3) : 285-299, 2004.
Hochhaus A and La Rosée P: Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance. Leukemia 18 (8): 1321-1331, 2004.
Cortes J, Hochhaus A, Hughes T, et al: Front-line and salvage therapies with tyrosine kinase inhibitors and other treatments in chronic myeloid leukemia.J Clin Oncol 29 (5) : 524-531, 2011.

ｍore...

, , ,

Return to Previous Page